BridgeMD
New treatment option for Tumoral Kidney
Official title Rein 3D PRINT PERSONALIZE
ClinicalTrials.gov ID: NCT06379698
What this study is testing
- What it's testing
- The goal of this clinical trial is to compare preoperative information and patient experience using a personalized versus a generic 3D printed models of patients' tumoral kidney before and after nephron-sparing surgery. The main outcome measure will be based on semi-structured interviews with the patient and the carers.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients:
- Adult patients (≥ 18 years of age)
- Scheduled for surgical management by laparoscopic robotic-assisted partial nephrectomy (1st management for a unilateral or bilateral kidney tumor)
- Expressed consent for integration in the UroCCR database
- Expressed consent for participation in the Rein-3D Personalize study
You likely can't join if
- Patients
- Metastatic at inclusion
- Previous renal cancer(s)
- Single kidney at time of inclusion
- No preoperative CT scan, or poor-quality CT scan unable to provide reliable 3D modeling
- Person under legal protection (safeguard of justice, guardianship or curatorship)
See the full eligibility criteria
- Patients:
- Adult patients (≥ 18 years of age)
- Scheduled for surgical management by laparoscopic robotic-assisted partial nephrectomy (1st management for a unilateral or bilateral kidney tumor)
- Expressed consent for integration in the UroCCR database
- Expressed consent for participation in the Rein-3D Personalize study
- Patients affiliated or benefiting from social security system Professionals:
- Professionals working with patients treated in the Urology, Andrology and Renal Transplant - Department of the Bordeaux University Hospital for at least two months prior to the implementation of 3D models
- Free, informed and signed consent
- Patients
- Metastatic at inclusion
- Previous renal cancer(s)
- Single kidney at time of inclusion
- No preoperative CT scan, or poor-quality CT scan unable to provide reliable 3D modeling
- Person under legal protection (safeguard of justice, guardianship or curatorship)
- Difficulty understanding and expressing oneself in French Professionals
- Professionals on internship lasting less than 6 months
- Professionals with no contact with patients
The study team makes the final eligibility decision.
Where it's taking place
- Bordeaux, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bordeaux, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.